| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/01/2023 | 14.07% | Stephens & Co. | $8 → $9 | Maintains | Equal-Weight |
| 06/02/2023 | 39.42% | Barrington Research | $10 → $11 | Maintains | Outperform |
| 05/24/2023 | 26.74% | Barrington Research | $8 → $10 | Maintains | Outperform |
| 03/21/2023 | 1.39% | Barrington Research | $10 → $8 | Maintains | Outperform |
| 03/20/2023 | 1.39% | Barrington Research | $10 → $8 | Maintains | Outperform |
| 03/20/2023 | -74.65% | Stephens & Co. | $11 → $2 | Downgrades | Overweight → Equal-Weight |
| 03/17/2023 | 39.42% | Stephens & Co. | → $11 | Reiterates | → Overweight |
What is the target price for Lifecore Biomedical (LFCR)?
The latest price target for Lifecore Biomedical (NASDAQ: LFCR) was reported by Stephens & Co. on September 1, 2023. The analyst firm set a price target for $9.00 expecting LFCR to rise to within 12 months (a possible 14.07% upside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Lifecore Biomedical (LFCR)?
The latest analyst rating for Lifecore Biomedical (NASDAQ: LFCR) was provided by Stephens & Co., and Lifecore Biomedical maintained their equal-weight rating.
When is the next analyst rating going to be posted or updated for Lifecore Biomedical (LFCR)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Lifecore Biomedical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Lifecore Biomedical was filed on September 1, 2023 so you should expect the next rating to be made available sometime around September 1, 2024.
Is the Analyst Rating Lifecore Biomedical (LFCR) correct?
While ratings are subjective and will change, the latest Lifecore Biomedical (LFCR) rating was a maintained with a price target of $8.00 to $9.00. The current price Lifecore Biomedical (LFCR) is trading at is $7.89, which is out of the analyst's predicted range.